Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × binimetinib × Clear all

NCT01352273 2020-09-30

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors